Placeholder

July 29, 2026

P&G Announces Fourth Quarter and Fiscal Year 2026 Results

Q4 ’26: Net Sales +2%; Organic Sales 0%; Diluted EPS -15%; Core EPS -3%

FY ’26: Net Sales +3%; Organic Sales +1%; Diluted EPS +2%; Core EPS +1%

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) reported fourth quarter and fiscal year 2026 results.



“Fiscal 2026 was a year of foundation building while continuing to grow sales and profit and return high levels of cash to shareowners despite a very challenging geopolitical and economic environment,” said Shailesh Jejurikar, President and Chief Executive Officer. “In fiscal 2027, we expect to deliver progress on each of these key measures despite continued volatility. We believe the best path to sustainable, balanced growth is to double down on our strategy and put the consumer first in everything we do. Stronger, integrated execution to delight consumers with superior products at a superior value. We are confident in our plans to accelerate growth from semester-to-semester, and our investments will be funded with a strong productivity program. We are building momentum with consumers, and we are excited about the long-term opportunities ahead.”

Fiscal Year ($ billions, except EPS)

GAAP

2026

2025

% Change

 

Non-GAAP*

2026

2025

% Change

Net Sales

$87.0

$84.3

+3%

 

Organic Sales

n/a

n/a

+1%

Diluted EPS

$6.62

$6.51

+2%

 

Core EPS

$6.89

$6.83

+1%

 

 

 

 

 

 

 

 

 

Fourth Quarter ($ billions, except EPS)

GAAP

2026

2025

% Change

 

Non-GAAP*

2026

2025

% Change

Net Sales

$21.2

$20.9

+2%

 

Organic Sales

n/a

n/a

—%

Diluted EPS

$1.26

$1.48

(15)%

 

Core EPS

$1.43

$1.48

(3)%

* Please refer to Exhibit 1 - Non-GAAP Measures for the definition and reconciliation of these measures to the related GAAP measures.

Fiscal Year 2026 Results

The Company reported fiscal year 2026 net sales of $87.0 billion, an increase of three percent versus the prior year, comprised of a two percent increase due to favorable foreign exchange impacts and a one percent increase from higher pricing. Volume and mix were unchanged versus prior year. Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, increased one percent from higher pricing.

Diluted net earnings per share were $6.62, an increase of two percent versus prior year, as the increase in net sales and a reduction in shares outstanding were partially offset by a reduction in gross margin and an increase in selling, general and administrative costs (SG&A). Core net earnings per share increased by one percent to $6.89. Currency-neutral core EPS was unchanged versus the prior year core EPS.

The Company generated operating cash flow of $19.6 billion and net earnings of $16.1 billion for the fiscal year. Adjusted free cash flow productivity was 100%, which is calculated as operating cash flow less capital spending and certain other items, as a percentage of net earnings excluding the gain from the dissolution of the Glad joint venture business in fiscal year 2026.

The Company returned over $15 billion of value to shareholders in fiscal 2026, comprised of $10.2 billion in dividend payments and $5.0 billion of share repurchases. With the dividend increase in April 2026, this marks the 70th consecutive year that P&G has increased its dividend and the 136th consecutive year that P&G has paid a dividend since its incorporation in 1890.

April-June Quarter Results

The Company reported fiscal year 2026 fourth quarter net sales of $21.2 billion, an increase of two percent versus the prior year. Foreign exchange and rounding each contributed one percent. Volume, pricing and mix had a neutral impact on sales growth for the quarter. Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, were unchanged versus the prior year.

Diluted net earnings per share were $1.26, a decrease of fifteen percent versus the prior year as an increase in net sales was more than offset by an increase in selling, general and administrative costs (SG&A) and a decrease in gross margin. Core net earnings per share decreased three percent to $1.43. Currency-neutral core EPS decreased five percent versus the prior year core EPS.

Operating cash flow was $5.1 billion and net earnings were $3.1 billion, with adjusted free cash flow productivity of 133%.

April-June Quarter Business Discussion

April - June 2026

Volume

Foreign
Exchange

Price

Mix

Other (2)

Net Sales

Organic
Volume

Organic
Sales

Net Sales Drivers (1)

Beauty

3%

2%

1%

—%

—%

6%

3%

4%

Grooming

(1)%

1%

1%

(1)%

1%

1%

(1)%

—%

Health Care

(3)%

2%

2%

1%

(1)%

1%

(3)%

(1)%

Fabric & Home Care

1%

—%

—%

—%

—%

1%

1%

—%

Baby, Feminine & Family Care

(1)%

1%

(1)%

—%

—%

(1)%

(1)%

(2)%

Total P&G

—%

1%

—%

—%

1%

2%

—%

—%

(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

(2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

  • Beauty segment organic sales increased four percent versus year ago. Hair Care organic sales increased mid-single digits driven by volume growth in Asia Pacific and Europe, innovation-driven pricing in Latin America and Asia Pacific and favorable geographic mix. Personal Care organic sales increased mid-single digits driven by volume growth across all regions and higher pricing, primarily in North America, partially offset by unfavorable geographic mix. Skin Care organic sales were unchanged as favorable product mix, led by growth of the super-premium SK-II brand, was offset by a volume decline in Greater China.
  • Grooming segment organic sales were unchanged versus year ago as the impacts of innovation-based pricing were offset by the impacts of a volume decline, primarily in IMEA, and unfavorable product mix.
  • Health Care segment organic sales decreased one percent versus year ago. Oral Care organic sales decreased mid-single digits driven by a volume decline, led by North America and Greater China. Personal Health Care organic sales increased mid-single digits driven by higher pricing and a volume increase, primarily in North America.
  • Fabric and Home Care segment organic sales were unchanged versus year ago. Fabric Care organic sales increased low single digits driven primarily by volume growth, led by Europe, and favorable product mix, partially offset by merchandising investments, primarily in North America. Home Care organic sales decreased low single digits due to volume decline, partially offset by higher pricing, both primarily in North America.
  • Baby, Feminine and Family Care segment organic sales decreased two percent versus year ago. Baby Care organic sales increased low single digits driven by volume growth, led by Greater China, and favorable product mix, partially offset by lower pricing. Feminine Care organic sales decreased low single digits driven by a volume decline, primarily in Europe, partially offset by favorable geographic mix. Family Care organic sales decreased mid-single digits driven by a volume decline, merchandising investments and unfavorable product mix.

Reported gross margin for the quarter decreased 60 basis points versus year ago. Core gross margin for the quarter and currency-neutral Core gross margin were unchanged versus year ago. Core gross margin was unchanged as 160 basis points of productivity savings, 40 basis points of net tariff benefit from recognized recoveries and higher costs, 20 basis points of other miscellaneous items and rounding and 10 basis points of pricing benefit were offset by 120 basis points of unfavorable product mix, 70 basis points of product/package reinvestments and 40 basis points of higher commodity costs.

Reported selling, general and administrative expense (SG&A) as a percentage of sales increased 160 basis points versus the prior year. Core and currency-neutral SG&A as a percentage of sales each increased 130 basis points versus year ago. Core SG&A increased by 410 basis points of reinvestments, primarily in marketing, and 20 basis points of other miscellaneous items and rounding, partially offset by 300 basis points of productivity savings, which includes reductions across marketing and overhead costs.

Reported operating margin for the quarter decreased 220 basis points versus the prior year. Excluding 90 basis points of non-core restructuring charges, core operating margin and currency-neutral core operating margin for the quarter each decreased 130 basis points versus the prior year. Core operating margin included gross productivity savings of 460 basis points.

Focused Portfolio, Supply Chain and Productivity Plan

In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and invest in growth. The Company expects to incur non-core restructuring costs of approximately $1 to $1.6 billion before-tax over a two-year period. The Company incurred over half of the costs under this plan in fiscal 2026, with the remainder expected in fiscal 2027.

Fiscal Year 2027 Guidance

P&G expects fiscal year 2027 all-in sales growth in the range of one to three percent versus the prior year. The Company also expects organic sales growth in the range of one to three percent versus prior year. Included in this organic sales growth guidance is a headwind of 30 to 50 basis points from brand, product form and go-to-market discontinuations.

P&G expects fiscal year 2027 diluted net earnings per share growth in the range of one to five percent versus fiscal 2026 GAAP EPS of $6.62. GAAP EPS includes expected non-core restructuring charges of $0.13 to $0.17 per share. P&G expects its fiscal 2027 core earnings per share growth in the range of in-line to three percent versus fiscal 2026 core EPS of $6.89. This outlook equates to a range of $6.89 to $7.11 per share, with a mid-point estimate of $7.00, or an increase of one and a half percent.

The Company estimates a headwind of approximately $1 billion after-tax driven by higher raw materials, energy and transportation costs, $150 million after-tax from higher net interest expense, $150 million after-tax from lower non-operating income and $50 million after-tax from unfavorable foreign exchange rates. Combined, these impacts equate to a headwind of $0.56 per share for fiscal 2027, or an eight percent drag on core EPS growth.

The Company is not able to reconcile its forward-looking non-GAAP cash flow and tax rate measures without unreasonable efforts given the unpredictability of the timing and amounts of discrete items, such as acquisitions, divestitures, or impairments, which could significantly impact GAAP results.

P&G expects its core effective tax rate to be approximately 20% in fiscal 2027, in-line with fiscal 2026.

Capital spending is estimated to be in the range of four and a half to five and a half percent of fiscal 2027 net sales.

P&G expects adjusted free cash flow productivity of 85% to 90% and expects to pay around $10 billion in dividends and to repurchase approximately $5 billion of common shares in fiscal year 2027.

Forward-Looking Statements

Certain statements in this release, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result" and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law.

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, changes in global interest rates and rate differentials, currency exchange, pricing controls or tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, variability and unpredictability in trade relations, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, acts of war or terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices, social or environmental practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws, regulations, policies and related interpretations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity, data protection and data transfers, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to continue delivering progress towards our environmental sustainability ambitions.

For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

 

Three Months Ended June 30

 

Fiscal Year Ended June 30

 

 

2026

 

 

 

2025

 

 

% Chg

 

 

2026

 

 

 

2025

 

 

% Chg

NET SALES

$

21,203

 

 

$

20,889

 

 

2%

 

$

87,032

 

 

$

84,284

 

 

3%

Cost of products sold

 

10,920

 

 

 

10,631

 

 

3%

 

 

43,362

 

 

 

41,164

 

 

5%

GROSS PROFIT

 

10,283

 

 

 

10,258

 

 

—%

 

 

43,669

 

 

 

43,120

 

 

1%

Selling, general and administrative expense

 

6,334

 

 

 

5,903

 

 

7%

 

 

23,922

 

 

 

22,669

 

 

6%

OPERATING INCOME

 

3,949

 

 

 

4,355

 

 

(9)%

 

 

19,748

 

 

 

20,451

 

 

(3)%

Interest expense

 

(236

)

 

 

(212

)

 

11%

 

 

(877

)

 

 

(907

)

 

(3)%

Interest income

 

107

 

 

 

104

 

 

3%

 

 

430

 

 

 

469

 

 

(8)%

Other non-operating income/(expense), net

 

112

 

 

 

274

 

 

(59)%

 

 

1,076

 

 

 

154

 

 

599%

EARNINGS BEFORE INCOME TAXES

 

3,933

 

 

 

4,521

 

 

(13)%

 

 

20,377

 

 

 

20,167

 

 

1%

Income taxes

 

852

 

 

 

895

 

 

(5)%

 

 

4,233

 

 

 

4,102

 

 

3%

NET EARNINGS

 

3,081

 

 

 

3,626

 

 

(15)%

 

 

16,144

 

 

 

16,065

 

 

—%

Less: Net earnings/(loss) attributable to non controlling interests

 

37

 

 

 

11

 

 

236%

 

 

98

 

 

 

91

 

 

8%

NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE

$

3,044

 

 

$

3,615

 

 

(16)%

 

$

16,046

 

 

$

15,974

 

 

—%

 

 

 

 

 

 

 

 

 

 

 

 

EFFECTIVE TAX RATE

 

21.7

%

 

 

19.8

%

 

 

 

 

20.8

%

 

 

20.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET EARNINGS PER COMMON SHARE: (1)

 

 

 

 

 

 

 

 

 

 

 

Basic

$

1.28

 

 

$

1.51

 

 

(15)%

 

$

6.75

 

 

$

6.67

 

 

1%

Diluted

$

1.26

 

 

$

1.48

 

 

(15)%

 

$

6.62

 

 

$

6.51

 

 

2%

 

 

 

 

 

 

 

 

 

 

 

 

DIVIDENDS PER COMMON SHARE

$

1.0885

 

 

$

1.0568

 

 

3%

 

$

4.2589

 

 

$

4.0763

 

 

4%

Diluted Weighted Average Common Shares Outstanding

 

2,412.7

 

 

 

2,443.8

 

 

 

 

 

2,422.5

 

 

 

2,454.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPARISONS AS A % OF NET SALES

 

 

 

 

Basis Pt Change

 

 

 

 

 

Basis Pt Change

Gross margin

48.5%

 

49.1%

 

(60)

 

50.2%

 

51.2%

 

(100)

Selling, general and administrative expense

29.9%

 

28.3%

 

160

 

27.5%

 

26.9%

 

60

Operating margin

18.6%

 

20.8%

 

(220)

 

22.7%

 

24.3%

 

(160)

Earnings before income taxes

18.5%

 

21.6%

 

(310)

 

23.4%

 

23.9%

 

(50)

Net earnings

14.5%

 

17.4%

 

(290)

 

18.5%

 

19.1%

 

(60)

Net earnings attributable to Procter & Gamble

14.4%

 

17.3%

 

(290)

 

18.4%

 

19.0%

 

(60)

(1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

 

Amounts in millions of dollars except per share amounts or as otherwise specified. Certain columns and rows may not add due to rounding

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

 

Three Months Ended June 30, 2026

 

Net Sales

% Change
Versus Year
Ago

Earnings/(Loss) Before
Income Taxes

% Change
Versus Year
Ago

Net Earnings/(Loss)

% Change
Versus Year
Ago

Beauty

$

3,975

6%

$

588

 

(17)%

$

450

 

(19)%

Grooming

 

1,699

1%

 

414

 

(10)%

 

317

 

(15)%

Health Care

 

2,757

1%

 

449

 

(8)%

 

336

 

(10)%

Fabric & Home Care

 

7,432

1%

 

1,598

 

(9)%

 

1,233

 

(10)%

Baby, Feminine & Family Care

 

5,049

(1)%

 

1,078

 

(11)%

 

825

 

(13)%

Corporate

 

292

N/A

 

(194

)

N/A

 

(80

)

N/A

TOTAL

$

21,203

2%

$

3,933

 

(13)%

$

3,081

 

(15)%

 

Three Months Ended June 30, 2026

 

(Percent Change vs. Year Ago) (1)

 

Volume with
Acquisitions &
Divestitures

Volume Excluding
Acquisitions &
Divestitures

Foreign
Exchange

Price

Mix

Other (2)

Net Sales
Growth

Beauty

3%

3%

2%

1%

—%

—%

6%

Grooming

(1)%

(1)%

1%

1%

(1)%

1%

1%

Health Care

(3)%

(3)%

2%

2%

1%

(1)%

1%

Fabric & Home Care

1%

1%

—%

—%

—%

—%

1%

Baby, Feminine & Family Care

(1)%

(1)%

1%

(1)%

—%

—%

(1)%

TOTAL

—%

—%

1%

—%

—%

1%

2%

 

Fiscal Year Ended June 30, 2026

 

Net Sales

% Change
Versus Year
Ago

Earnings/(Loss) Before
Income Taxes

% Change
Versus Year
Ago

Net Earnings/(Loss)

% Change
Versus Year
Ago

Beauty

$16,023

7%

$3,473

1%

$2,672

(2)%

Grooming

6,918

4%

1,966

1%

1,529

(3)%

Health Care

12,456

4%

3,163

—%

2,404

(1)%

Fabric & Home Care

30,314

2%

7,290

(2)%

5,632

(4)%

Baby, Feminine & Family Care

20,401

1%

5,145

(1)%

3,930

(2)%

Corporate

919

N/A

(660)

N/A

(23)

N/A

TOTAL

$87,032

3%

$20,377

1%

$16,144

—%

 

Fiscal Year Ended June 30, 2026

 

(Percent Change vs. Year Ago) (1)

 

Volume with
Acquisitions &
Divestitures

Volume Excluding
Acquisitions &
Divestitures

Foreign
Exchange

Price

Mix

Other (2)

Net Sales
Growth

Beauty

4%

4%

2%

1%

—%

—%

7%

Grooming

(1)%

(1)%

3%

2%

—%

—%

4%

Health Care

(2)%

(2)%

3%

2%

1%

—%

4%

Fabric & Home Care

—%

—%

1%

1%

—%

—%

2%

Baby, Feminine & Family Care

(1)%

(1)%

2%

—%

—%

—%

1%

TOTAL

—%

—%

2%

1%

—%

—%

3%

(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

(2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.

 

Amounts in millions of dollars except per share amounts or as otherwise specified. Certain columns and rows may not add due to rounding.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Statements of Cash Flows

 

Fiscal Year Ended June 30

 

 

2026

 

 

 

2025

 

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR

$

9,556

 

 

$

9,482

 

OPERATING ACTIVITIES (1)

 

 

 

Net earnings

 

16,144

 

 

 

16,065

 

Depreciation and amortization

 

3,160

 

 

 

2,847

 

Share-based compensation expense

 

524

 

 

 

476

 

Deferred income taxes

 

51

 

 

 

149

 

(Gain)/loss on sale of assets

 

(351

)

 

 

755

 

Change in accounts receivable

 

84

 

 

 

45

 

Change in inventories

 

(641

)

 

 

(324

)

Change in accounts payable

 

919

 

 

 

(542

)

Other

 

(333

)

 

 

(1,653

)

TOTAL OPERATING ACTIVITIES

 

19,556

 

 

 

17,817

 

INVESTING ACTIVITIES

 

 

 

Capital expenditures

 

(4,409

)

 

 

(3,773

)

Proceeds from asset sales

 

508

 

 

 

107

 

Acquisitions, net of cash acquired

 

(85

)

 

 

(11

)

Other investing activity

 

(638

)

 

 

(141

)

TOTAL INVESTING ACTIVITIES

 

(4,624

)

 

 

(3,818

)

FINANCING ACTIVITIES

 

 

 

Dividends to shareholders

 

(10,232

)

 

 

(9,872

)

Additions to short-term debt with original maturities of more than three months

 

7,941

 

 

 

8,020

 

Reductions in short-term debt with original maturities of more than three months

 

(9,984

)

 

 

(6,512

)

Net additions/(reductions) to other short-term debt

 

2,674

 

 

 

(1,138

)

Additions to long-term debt

 

2,652

 

 

 

2,237

 

Reductions of long-term debt

 

(3,390

)

 

 

(1,977

)

Treasury stock purchases

 

(5,028

)

 

 

(6,500

)

Impact of stock options and other

 

907

 

 

 

1,707

 

TOTAL FINANCING ACTIVITIES

 

(14,460

)

 

 

(14,036

)

EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH

 

(86

)

 

 

112

 

CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

 

386

 

 

 

75

 

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR

$

9,942

 

 

$

9,556

 

(1) Certain prior period amounts within Operating Activities have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the previously reported Total Operating Activities.

 

Amounts in millions of dollars except per share amounts or as otherwise specified. Certain columns and rows may not add due to rounding.


Contacts

P&G Media Contacts:
Wendy Kennedy, 513.780.7212
Holly Stutz Smith, 513.659.9949

P&G Investor Relations Contact:
Keri Cowan, 513.983.2414


Read full story here